Am­gen and Hori­zon can close their $28B deal af­ter re­solv­ing law­suit by the FTC

Am­gen has set­tled with the Fed­er­al Trade Com­mis­sion af­ter the US reg­u­la­tor in May had tried block­ing the Cal­i­for­nia drug­mak­er’s pro­posed near­ly $28 bil­lion ac­qui­si­tion of Hori­zon Ther­a­peu­tics.

The deal is ex­pect­ed to close ear­ly next quar­ter now, the com­pa­nies said Fri­day morn­ing.

Am­gen and Hori­zon en­tered in­to a con­sent or­der agree­ment with the FTC, which will re­solve the agency’s pend­ing ad­min­is­tra­tive law­suit, the com­pa­nies said Fri­day morn­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER